Searchable abstracts of presentations at key conferences in endocrinology

ea0042p41 | (1) | Androgens2016

Characterisation of Androgen and Estrogen Receptor Cross-Talk

Alkheilewi Mohammad , Bryan Rosie , Brooke Greg

Worldwide, breast cancer is the most common cancer to develop in women. Steroid receptors play a key role in the progression of the majority of breast cancer subtypes. Estrogen Receptor-α (ERα), for example drives the growth of approximately 70% of tumours and is therefore a useful therapeutic target for this disease. However, the Androgen Receptor (AR) is the highest expressed receptor in normal breast and appears to also play an important role in breast cancer. In ...

ea0034p92 | Clinical practice/governance and case reports | SFEBES2014

An audit of clinical follow-up and management of adult patients with Turner's syndrome at the Royal Devon and Exeter

Whittle Elizabeth , Donohoe Mollie , Brooke Antonia

Introduction: Turners’ syndrome (TS) affects one in 2500 live births. Multiple comorbidities affect TS patients and recommendations for long-term management advocate annual review with a ‘checklist’ approach. This audit of current practice of a specialist TS clinic aims to identify gaps in patients’ management.Methods: A checklist of recommendations for health screening based on the National Turner’s Syndrome Guidelines was devel...

ea0091oc5 | Oral Communications | SFEEU2023

The success story of Osilodrostat for optimisation of severe Cushing’s Disease

Subramaniam Yuvanaa , Dorward Neil , Drake William M , Brooke Antonia M

A 51-year-old gentleman presented in June 2022 with pneumobilia, staph liver abscesses and rapidly conducted atrial fibrillation requiring ITU admission. He had a 2-year history of typical Cushingoid features and hypogonadism, 4 agent hypertension since 2012, fragility fractures, previous renal calculi, pulmonary emboli and diabetes. He had not been able to walk unaided for a year (was mobilising with crutches on admission). In retrospect, he had previously had a cortisol of 7...

ea0069p66 | Poster Presentations | SFENCC2020

A case of sellar paraganlioma; rarest of the rare

Khan Haider , Muquit Samiul , Shivane Aditya , Brooke Antonia

Introduction: Paragangliomas are neuroendocrine tumours, usually found from the base of the skull to pelvis. They are extremely rare in the sellar and parasellar region which normally lacks paraganglion cells. We report a rare case of an incidental sellar paraganglioma.Case: A 66 years old female had progressive retinopathy and maculopathy of unclear cause since 2011. Lung nodules were seen on CT performed to exclude paraneoplastic retinopathy. 18F-FDG P...

ea0034p46 | Clinical biochemistry | SFEBES2014

High testosterone? Look again!

Babiker Tarig , Perry Mandy , McDonald Timothy , Brooke Antonia , O'Connor John

Three premenopausal patients presented with high isolated testosterone without symptoms of androgen excess or illicit drug use.Case 1: A 22-year-old female presented with daily vaginal bleeds having been on depot injections of progesterone with supplementary norethisterone. Testosterone was 14.5 nmol/l with suppressed gonadotrophins (LH <0.1 IU/l, FSH 0.2 IU/l, oestradiol <19 pmol/l). Her norethisterone was stopped. A repeat biochemical profile a...

ea0034p149 | Clinical practice/governance and case reports | SFEBES2014

Adrenocortical carcinoma, where's the delay?

Aziz Aftab , Dyer Rob , Dunn Julie , Goodman Andy , Brooke Antonia

Adrenocortical carcinomas are rare malignancies (incidence 1–2/one million). They present in a variety of ways and carry a poor prognosis. Prompt diagnosis and early intervention offers better outcome.We describe 5 cases of adrenocortical carcinoma to help identify and improve delays in their pathway of care. Five patients (four females and one male), age range 38–76 years, presented between September 2011 and April 2013. Three patients referre...

ea0034p195 | Nursing practise | SFEBES2014

Intervention of ward visits by an endocrine nurse specialist and a protocol and in the management of hyponatraemia

Mason Rhianne , Forbes Charlotte , Williams Seren , McDonald Timothy , Brooke Antonia

Hyponatraemia is associated with an increase in morbidity and mortality, prolonged hospital stays and poor assessment and management. Two audits were performed looking at acute medical unit (AMU) admissions with sodium <130 mmol/l, before and after the introduction of a protocol and regular endocrine nurse specialist ward visits, 3 months apart (58 patients in April and 99 in July 2013).Hyponatraemic patients were older than the AMU population (>...

ea0029p269 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Testosterone replacement therapy inhibits key enzymes of fatty acid synthesis in mouse liver

Brooke J. , Kelly D. , Akhtar S. , Muraleedharan V. , Jones T.

Fatty liver (Hepatic Steatosis) is common in men with type 2 diabetes mellitus (T2DM). Furthermore there is a high prevalence of testosterone deficiency (up to 40%) in this population. Testosterone replacement therapy (TRT) has been shown to reduce elevated serum liver transaminase levels in hypogonadal men. The testicular feminised (Tfm) mouse exhibits a non-functional androgen receptor (AR) and low circulating testosterone levels. We have previously shown that a high-fat die...

ea0029p270 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Effect of testosterone on hepatic liver X receptor and ApoE expression as a potential mechanism of atheroprotection in the testicular feminised mouse

Kelly D. , Akhtar S. , Brooke J. , Channer K. , Jones T.

Testosterone deficiency is associated with several cardiovascular risk factors. Testosterone replacement therapy (TRT) improves insulin sensitivity, inflammation and cholesterol. Liver X receptor (LXR) is a nuclear receptor which regulates lipid and glucose metabolism, stimulates cholesterol efflux and ApoE, and suppresses inflammation. LXR agonists cause hepatic steatosis but protect against atherosclerosis. TRT attenuates high-cholesterol diet-induced hepatic steatosis in th...

ea0029p273 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Testosterone replacement therapy: a safety audit of clinical practice including men with Type 2 diabetes and cardiovascular disease

Brooke J. , Walter D. , Muraleedharan V. , Jones T.

Hypogonadism is highly prevalent in men with type 2 diabetes (T2D) and/or cardiovascular disease (CVD). Low testosterone levels are associated with CVD risk factors including obesity, insulin resistance, dyslipidaemia and hypertension. Testosterone replacement therapy (TRT) has been shown to have beneficial effects on these parameters; however, safety needs to be verified. An audit of 308 (50% with T2D, 32.1% CVD, 82.8% ED) hypogonadal men (age 59.02±13.23 years; mean bas...